Some Americans are turning to a medication approved to treat parasitic infections and skin conditions as an answer against COVID-19, despite the lack of data supporting ivermectin's use against the novel coronavirus. That’s why the U.S.
In what is being called the first-ever test of open-source drug-discovery, researchers from around the world have successfully identified compounds to pursue in treating and preventing parasite-borne illnesses such as malaria as well as cancer.
A class of white cells that has long been thought to play a relatively minor role in the body’s defenses against malaria infection may, in fact, be a potent weapon against the malaria parasite.
